Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12606000358549
Ethics application status
Not yet submitted
Date submitted
18/04/2006
Date registered
18/08/2006
Date last updated
18/08/2006
Type of registration
Retrospectively registered

Titles & IDs
Public title
Impact of Glycopyrrolate on Carotid Angioplasty and Stenting
Scientific title
Prophylactic glycopyrrolate vs placebo in carotid angioplasty and stenting for carotid stenosis to prevent bradycardia and/or hypotension and improve post-operative outcome.
Universal Trial Number (UTN)
Trial acronym
GCAS
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Carotid angioplasty and stenting for carotid stenosis 1327 0
Condition category
Condition code
Cardiovascular 1415 1415 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Glycopyrrolate
1. Dosage of drug: Glycopyrrolate 0.2-0.4mg
Frequency: Once only at not less than 6 mins before balloon inflation but not more than 2 hours before balloon inflation
Mode: intravenous
2. Intervention group: Receives glycopyrrolate
3. Control group: Receives normal saline (placebo)
4. Duration of intervention: Once only administration of glycopyrrolate given as detailed above.
Intervention code [1] 987 0
Prevention
Comparator / control treatment
Placebo
Control group
Placebo

Outcomes
Primary outcome [1] 1936 0
Reduction in intra-operative bradycardia and/or hypotension
Timepoint [1] 1936 0
Intra-operative
Secondary outcome [1] 3396 0
Reduction in post-operative cardiovascular and neurological morbidity and mortality.
Timepoint [1] 3396 0
Post-operative till discharge (usually 3 days).

Eligibility
Key inclusion criteria
All patients for carotid angioplasty and stenting.
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Inability to consent, patient refusal, allergy to glycopyrrolate.

Study design
Purpose of the study
Prevention
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Non-participating anaesthetist will draw up glycopyrrolate or placebo and give it to be administered by the participating anaesthetist.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Simple randomisation via computer software
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Type of endpoint/s
Safety
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/08/2006
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
60
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)

Funding & Sponsors
Funding source category [1] 1547 0
Hospital
Name [1] 1547 0
Dept. of Anaesthesia, St. Vincent’s Hospital
Country [1] 1547 0
Australia
Primary sponsor type
Individual
Name
Dr Crispin Wan
Address
Country
Secondary sponsor category [1] 1360 0
Individual
Name [1] 1360 0
Assoc. Prof. Michael Davies
Address [1] 1360 0
Country [1] 1360 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 2976 0
St. Vincent's Hospital, Melbourne
Ethics committee address [1] 2976 0
Ethics committee country [1] 2976 0
Australia
Date submitted for ethics approval [1] 2976 0
Approval date [1] 2976 0
Ethics approval number [1] 2976 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 35183 0
Address 35183 0
Country 35183 0
Phone 35183 0
Fax 35183 0
Email 35183 0
Contact person for public queries
Name 10176 0
Dr Crispin Wan
Address 10176 0
Department of Anaesthesia
St. Vincent’s Hospital
PO Box 2900
Fitzroy VIC 3065
Country 10176 0
Australia
Phone 10176 0
+61 3 92882211
Fax 10176 0
Email 10176 0
cwan@sent.com
Contact person for scientific queries
Name 1104 0
Dr Crispin Wan
Address 1104 0
Department of Anaesthesia
St. Vincent’s Hospital
PO Box 2900
Fitzroy VIC 3065
Country 1104 0
Australia
Phone 1104 0
+61 3 92882211
Fax 1104 0
Email 1104 0
cwan@sent.com

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.